PCR ASSESSMENT OF BONE-MARROW STATUS IN ISOLATED EXTRAMEDULLARY RELAPSE OF CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA

被引:52
作者
GOULDEN, N
LANGLANDS, K
STEWARD, C
KATZ, F
POTTER, M
CHESSELLS, J
OAKHILL, A
机构
[1] UNIV BRISTOL,SCH MED SCI,DEPT PATHOL & MICROBIOL,BRISTOL,ENGLAND
[2] INST CHILD HLTH,LONDON,ENGLAND
关键词
ALL; EXTRAMEDULLARY RELAPSE; MINIMAL RESIDUAL DISEASE; PCR;
D O I
10.1111/j.1365-2141.1994.tb04910.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Approximately one-third of first relapses of childhood ALL occur at an extramedullary site without morphological evidence of bone marrow disease. However, the high incidence of subsequent medullary relapse in these cases strongly suggests that leukaemia is present at submicroscopic levels at the time of 'isolated' relapse. PCR analysis of immunoglobulin heavy chain (IgH) and T-cell receptor (TCR) gene rearrangements now allows detection of leukaemia at levels as low as 0.001%. We have therefore used this technique to reassess bone mac-row status at morphologically isolated relapse in 13 children with B-lineage ALL (11 with off-treatment relapses, two on treatment). In 12 of these 13 patients marrow disease was detectable by PCR at the time of this relapse-in all cases at levels below the threshold of light microscopy. Where relapse occurred off-therapy this indicated re-emergence of disease, since MRD has never been detected by PCR at this stage in patients remaining in long-term remission. In both patients who relapsed an-therapy the level of MRD at the time of relapse represented an increase on that seen in their previous marrow sample, We conclude that re-emerging bone marrow disease can be detected in most cases of 'isolated' relapse when investigated by this highly sensitive technique. Our findings at a molecular level confirm a long-held clinical suspicion and indicate that full systemic re-induction as well as local therapy is obligatory for these children.
引用
收藏
页码:282 / 285
页数:4
相关论文
共 21 条
  • [1] BARTRAM CR, 1993, HAEMATOLOGY TRENDS 9, P234
  • [2] BIONDI A, 1992, LEUKEMIA, V6, P282
  • [3] BLEYER WA, 1988, PEDIATR CLIN N AM, V35, P789
  • [4] MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA DETECTED BY IMMUNE SELECTION AND GENE REARRANGEMENT ANALYSIS
    BREGNI, M
    SIENA, S
    NERI, A
    BASSAN, R
    BARBUI, T
    DELIA, D
    BONADONNA, G
    FAVERA, RD
    GIANNI, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 338 - 343
  • [5] EDEN OB, 1978, BRIT MED J, V1, P334
  • [6] EVANS AE, 1964, CANCER, V17, P256, DOI 10.1002/1097-0142(196402)17:2<256::AID-CNCR2820170216>3.0.CO
  • [7] 2-3
  • [8] HANSENHAGGE TE, 1989, BLOOD, V74, P1762
  • [9] MOLECULAR RESIDUAL DISEASE STATUS AT THE END OF CHEMOTHERAPY FAILS TO PREDICT SUBSEQUENT RELAPSE IN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    ITO, Y
    WASSERMAN, R
    GALILI, N
    REICHARD, BA
    SHANE, S
    LANGE, B
    ROVERA, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 546 - 553
  • [10] THE USE OF DNA PROBES TO MONITOR MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    KATZ, F
    BALL, L
    GIBBONS, B
    CHESSELLS, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (02) : 173 - 180